One Teen’s Guide: Tips for Living with Severe Eczema
One teen’s guide on living with severe eczema, and the tips that make a difference Living with severe eczema was a daily challenge for William. Still, his grit has led to remarkable achievements: a second-degree black belt in taekwondo and winning one gold and two silver medals at the 2025 ICTF Open World Taekwondo, receiving […]
Ask the doctor about Cibinqoᴹᴰ (abrocitinib)
Learn more about oral JAK inhibitors for atopic dermatitis from dermatologist Dr. Ashley Sutherland Eczema Society of Canada asked dermatologist Ashley Sutherland, MD, MSc, FRCPC, to share her expertise on the oral JAK inhibitor Cibinqo® (abrocitinib) and how this medication is used to manage atopic dermatitis (AD), the most common form of eczema. What are […]
Ask the doctor about Protopic® (tacrolimus)
Learn more about a topical calcineurin inhibitor for atopic dermatitis from dermatologist Dr. Cathryn Sibbald Eczema Society of Canada asked Toronto-based dermatologist Cathryn Sibbald, MD, MSc, FRCPC, DABD, to share her expertise on the topical calcineurin inhibitor Protopic® (tacrolimus) and how this medication is used to manage atopic dermatitis (AD), commonly known as eczema. What […]
Ask the doctor about Dupixent® (dupilumab)
Learn more about a biologic drug for atopic dermatitis: insights from dermatologist Dr. Rachel Asiniwasis Eczema Society of Canada asked dermatologist and researcher Rachel Asiniwasis, MD, FRCPC, to share her expertise on the biologic drug Dupixent® (dupilumab) and how this medication is used to manage atopic dermatitis (AD), the most common form of eczema. What […]
Ask the doctor about topical corticosteroids
Learn more about topical corticosteroids from dermatologist Dr. Cathryn Sibbald Topical corticosteroids are a group of medications often used in the management of atopic dermatitis (AD), the most common form of eczema. To explore this topic further, Toronto-based dermatologist Cathryn Sibbald, MD, MSc, FRCPC, DABD, shared her expertise on topical corticosteroids and how they are […]
Ask the Doctor About Anzupgo® (delgocitinib)
Learn more about a pan-JAK inhibitor for the management of chronic hand eczema: insights from dermatologist Dr. Sonja Molin ESC asked dermatologist and researcher Sonja Molin, MD, to share her expertise on the pan-JAK inhibitor Anzupgo® (delgocitinib) and how this medication is used to manage CHE. What is Chronic Hand Eczema? Chronic hand eczema (CHE) […]
Ask the doctor about Eucrisa™ (crisaborole)
Learn more about a topical PDE4 inhibitor for atopic dermatitis from dermatologist Dr. Maxwell B. Sauder Topical PDE4 (phosphodiesterase 4) inhibitors are steroid-free eczema therapies that have been available in Canada since 2018. Topical PDE4 offer another option to help manage atopic dermatitis. Eczema Society of Canada asked dermatologist Maxwell B. Sauder, MD, FRCPC, FAAD, […]
Ask the doctor about Elidelᴹᴰ (pimecrolimus)
Learn more about a topical calcineurin inhibitor for atopic dermatitis from dermatologist Dr. Cathryn Sibbald Eczema Society of Canada asked Toronto-based dermatologist Cathryn Sibbald, MD, MSc, FRCPC, DABD, to share her expertise on the topical calcineurin inhibitor Elidel® (pimecrolimus) and how this medication is used to manage atopic dermatitis (AD), commonly known as eczema. What […]
Ask the doctor about EbglyssMC (lebrikizumab)
Learn more about biologic drugs: insights from dermatologist Dr. Rachel Asiniwasis ESC asked dermatologist and researcher Rachel Asiniwasis, MD, FRCPC, to share her expertise on the biologic drug Ebglyss™(lebrikizumab) and how this medication is used to manage atopic dermatitis (AD), the most common form of eczema. What are biologic drugs? Biologic drugs sometimes called “biologics”, […]
Ask the doctor about Zoryve® (roflumilast)
Learn more about a topical PDE4 inhibitor for atopic dermatitis from dermatologist Dr. Maxwell B. Sauder Topical PDE4 (phosphodiesterase 4) inhibitors are steroid-free eczema therapies that have been available in Canada since 2018. Topical PDE4 offer another option to help manage atopic dermatitis. Eczema Society of Canada asked dermatologist Maxwell B. Sauder, MD, FRCPC, FAAD, […]
Ask the doctor about Rinvoq® (upadacitinib)
Learn more about oral JAK inhibitors for atopic dermatitis from dermatologist Dr. Ashley Sutherland Eczema Society of Canada asked dermatologist Ashley Sutherland, MD, MSc, FRCPC, to share her expertise on the oral JAK inhibitor Rinvoq® (upadacitinib) and how this medication is used to manage atopic dermatitis (AD), the most common form of eczema. What are […]
Ask the doctor about Opzelura® (ruxolitinib)
Learn more about a topical JAK inhibitor for atopic dermatitis from dermatologist Dr. Ashley Sutherland ESC asked dermatologist Ashley Sutherland, MD, MSc, FRCPC, to share her expertise on the topical JAK inhibitor Opzelura® (ruxolitinib) and how this medication is used to manage atopic dermatitis (AD), the most common form of eczema. What are topical JAK […]